NEW YORK (GenomeWeb News) – Bruker reported after the close of the market Wednesday that its revenues in the first quarter were up 8 percent year over year, rising to $423.7 million from $393.4 million in Q1 2013.

The results beat the average Wall Street estimate of $402.0 million. Acquisitions and divestitures were responsible for a net positive effect of roughly 1 percent, while foreign currency effects were negligible in the quarter, the company said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.

Oct
10
Sponsored by
Philips Genomics

This webinar will provide a first-hand look at how the Dana-Farber Cancer Center is adapting its oncology care strategy in light of the rapidly evolving molecular landscape.